Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2019

Ausgabe 2/2019

Inhaltsverzeichnis ( 26 Artikel )

26.02.2019 | Review | Ausgabe 2/2019

The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review

Dustin H. Marks, Jean-Phillip Okhovat, Dina Hagigeorges, Athena J. Manatis-Lornell, Steven J. Isakoff, Mario E. Lacouture, Maryanne M. Senna

27.02.2019 | Review | Ausgabe 2/2019

The next generation personalized models to screen hidden layers of breast cancer tumorigenicity

F. Afzali, P. Akbari, H. Naderi-Manesh, M. Gardaneh

12.02.2019 | Preclinical study | Ausgabe 2/2019 Open Access

Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up

Sherry X. Yang, Eric C. Polley

12.02.2019 | Preclinical study | Ausgabe 2/2019

Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion

Landry K. Kamdem, Jingyue Xi, Brandi L. Clark, Bryana J. Gregory, Kelley M. Kidwell, Ana-Maria Storniolo, Vered Stearns, Daniel F. Hayes, Christina L. Gersch, James M. Rae, N. Lynn Henry, Daniel L. Hertz

22.02.2019 | Preclinical study | Ausgabe 2/2019 Open Access

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast

Ulrik Narbe, Martin Sjöström, Carina Forsare, Pär-Ola Bendahl, Sara Alkner, L. M. Fredrik Leeb-Lundberg, Kristina Lövgren, Lisa Rydén, Christian Ingvar, Mårten Fernö

22.02.2019 | Preclinical study | Ausgabe 2/2019 Open Access

Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach

Mariana Ferreira Leal, Ben P. Haynes, Fiona A. MacNeill, Andrew Dodson, Mitch Dowsett

23.02.2019 | Preclinical study | Ausgabe 2/2019

SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma

Emily A. Bossart, Nilgun Tasdemir, Matthew J. Sikora, Amir Bahreini, Kevin M. Levine, Jian Chen, Ahmed Basudan, Britta M. Jacobsen, Timothy F. Burns, Steffi Oesterreich

02.03.2019 | Preclinical study | Ausgabe 2/2019

Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer

Jangsoon Lee, Bora Lim, Troy Pearson, Kuicheon Choi, Jon A. Fuson, Chandra Bartholomeusz, Linda J. Paradiso, Thomas Myers, Debu Tripathy, Naoto T. Ueno

04.03.2019 | Preclinical study | Ausgabe 2/2019

ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer

Zhanwei Wang, Dionyssios Katsaros, Nicoletta Biglia, Yi Shen, Lenora Loo, Xiao Yu, Hongyan Lin, Yuanyuan Fu, Wen-Ming Chu, Peiwen Fei, Yan Ni, Wei Jia, Xiaobei Deng, Biyun Qian, Herbert Yu

12.02.2019 | Clinical trial | Ausgabe 2/2019 Open Access

Breast sensibility after mastectomy and implant-based breast reconstruction

E. Bijkerk, S. M. J. van Kuijk, J. Beugels, A. J. M. Cornelissen, E. M. Heuts, R. R. W. J. van der Hulst, S. M. H. Tuinder

13.02.2019 | Clinical Trial | Ausgabe 2/2019

Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit

Alexandre de Nonneville, Camille Jauffret, Anthony Gonçalves, Jean-Marc Classe, Monique Cohen, Fabien Reyal, Chafika Mazouni, Marie-Pierre Chauvet, Nicolas Chopin, Pierre-Emmanuel Colombo, Eva Jouve, Emile Darai, Roman Rouzier, Charles Coutant, Pierre Gimbergues, Anne-Sophie Azuar, Christine Tunon de Lara, Eric Lambaudie, Gilles Houvenaeghel

22.02.2019 | Clinical trial | Ausgabe 2/2019 Open Access

Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study

R. Wuerstlein, R. Kates, O. Gluz, E. M. Grischke, C. Schem, M. Thill, S. Hasmueller, A. Köhler, B. Otremba, F. Griesinger, C. Schindlbeck, A. Trojan, F. Otto, M. Knauer, R. Pusch, N. Harbeck, WSG-PRIMe investigators in Germany, Austria, Switzerland

26.02.2019 | Clinical trial | Ausgabe 2/2019

Loss of HER2 after HER2-targeted treatment

Tanja Ignatov, Franceska Gorbunow, Holm Eggemann, Olaf Ortmann, Atanas Ignatov

28.02.2019 | Clinical trial | Ausgabe 2/2019

Extent of resection and role of adjuvant treatment in resected localized breast angiosarcoma

Shearwood McClelland III, Jess Hatfield, Catherine Degnin, Yiyi Chen, Timur Mitin

06.04.2019 | Clinical trial | Ausgabe 2/2019 Open Access

Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval

Ingrid G. M. Poodt, Robert-Jan Schipper, Bianca T. A. de Greef, Guusje Vugts, Adriana J. G. Maaskant-Braat, Frits H. Jansen, Dirk N. J. Wyndaele, Adri C. Voogd, Grard A. P. Nieuwenhuijzen, the Sentinel Node And Recurrent Breast Cancer (SNARB) Research Group

12.02.2019 | Epidemiology | Ausgabe 2/2019 Open Access

The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients

M. L. Gregorowitsch, A. Ghedri, D. A. Young-Afat, R. Bijlsma, I. O. Baas, C. van Schaik-van de Mheen, M. J. Agterof, E. Göker, D. ten Bokkel Huinink, H. J. G. D. van den Bongard, H. M. Verkooijen, UMBRELLA study group

12.02.2019 | Epidemiology | Ausgabe 2/2019

Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers

Joanne Kotsopoulos, Jan Lubinski, Henry T. Lynch, Nadine Tung, Susan Armel, Leigha Senter, Christian F. Singer, Robert Fruscio, Fergus Couch, Jeffrey N. Weitzel, Beth Karlan, William D. Foulkes, Pal Moller, Andrea Eisen, Peter Ainsworth, Susan L. Neuhausen, Olufunmilayo Olopade, Ping Sun, Jacek Gronwald, Steven A. Narod, the Hereditary Breast Cancer Clinical Study Group

13.02.2019 | Epidemiology | Ausgabe 2/2019 Open Access

Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material

A. M. Sofie Berghuis, Carolien H. M. van Deurzen, Hendrik Koffijberg, Leon W. M. M. Terstappen, Stefan Sleijfer, Maarten J. IJzerman

19.02.2019 | Epidemiology | Ausgabe 2/2019 Open Access

A high-risk luminal A dominant breast cancer subtype with increased mobility

Liping Guo, Guoji Chen, Wen Zhang, Lulin Zhou, Ting Xiao, Xuebing Di, Yipeng Wang, Lin Feng, Kaitai Zhang

22.02.2019 | Epidemiology | Ausgabe 2/2019

Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis

Stephanie R. Rice, Steven J. Feigenberg, Muhammad Hamza, Jason K. Molitoris, Søren M. Bentzen, Katherine H. R. Tkaczuk, Paula M. Rosenblatt, Emily C. Bellavance, Elizabeth M. Nichols

22.02.2019 | Epidemiology | Ausgabe 2/2019 Open Access

Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors

Gitana Maria Aceto, Khalid Dafaallah Awadelkarim, Marta Di Nicola, Carmelo Moscatello, Mattia Russel Pantalone, Fabio Verginelli, Nasr Eldin Elwali, Renato Mariani-Costantini

01.03.2019 | Epidemiology | Ausgabe 2/2019 Open Access

Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands

Carmen van Dooijeweert, Ivette A. G. Deckers, Inge O. Baas, Elsken van der Wall, Paul J. van Diest

02.03.2019 | Epidemiology | Ausgabe 2/2019

Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany

Daniela Doege, Melissa Suk-Yin Thong, Lena Koch-Gallenkamp, Heike Bertram, Andrea Eberle, Bernd Holleczek, Ron Pritzkuleit, Mechthild Waldeyer-Sauerland, Annika Waldmann, Sylke Ruth Zeissig, Lina Jansen, Hermann Brenner, Volker Arndt

12.02.2019 | Brief report | Ausgabe 2/2019 Open Access

Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients

Chara Stavraka, Athanasios Pouptsis, Leroy Okonta, Karen DeSouza, Philip Charlton, Matthaios Kapiris, Anthony Marinaki, Eleni Karapanagiotou, Dionysis Papadatos-Pastos, Janine Mansi

22.02.2019 | Brief Report | Ausgabe 2/2019

Validation of the breast cancer surveillance consortium model of breast cancer risk

Jeffrey A. Tice, Michael C. S. Bissell, Diana L. Miglioretti, Charlotte C. Gard, Garth H. Rauscher, Firas M. Dabbous, Karla Kerlikowske

28.02.2019 | Brief Report | Ausgabe 2/2019

Corneal features in trastuzumab emtansine treatment: not a rare occurrence

Els Deklerck, Hannelore Denys, Elke O. Kreps

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise